Celldex (CLDX) Posts Smaller Q4 Loss

March 7, 2018 4:02 PM

Celldex (NASDAQ: CLDX) reported Q4 EPS of ($0.03), $0.22 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $1.35 million.

For earnings history and earnings-related data on Celldex (CLDX) click here.


Earnings Guidance

Next Articles